S35F2_HUMAN - dbPTM
S35F2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID S35F2_HUMAN
UniProt AC Q8IXU6
Protein Name Solute carrier family 35 member F2
Gene Name SLC35F2
Organism Homo sapiens (Human).
Sequence Length 374
Subcellular Localization Membrane
Multi-pass membrane protein .
Protein Description Putative solute transporter..
Protein Sequence MEADSPAGPGAPEPLAEGAAAEFSSLLRRIKGKLFTWNILKTIALGQMLSLCICGTAITSQYLAERYKVNTPMLQSFINYCLLFLIYTVMLAFRSGSDNLLVILKRKWWKYILLGLADVEANYVIVRAYQYTTLTSVQLLDCFGIPVLMALSWFILHARYRVIHFIAVAVCLLGVGTMVGADILAGREDNSGSDVLIGDILVLLGASLYAISNVCEEYIVKKLSRQEFLGMVGLFGTIISGIQLLIVEYKDIASIHWDWKIALLFVAFALCMFCLYSFMPLVIKVTSATSVNLGILTADLYSLFVGLFLFGYKFSGLYILSFTVIMVGFILYCSTPTRTAEPAESSVPPVTSIGIDNLGLKLEENLQETHSAVL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MEADSPAG
-------CCCCCCCC
9.6322814378
5Phosphorylation---MEADSPAGPGAP
---CCCCCCCCCCCC
24.5725159151
24PhosphorylationEGAAAEFSSLLRRIK
HCHHHHHHHHHHHHH
16.1624043423
25PhosphorylationGAAAEFSSLLRRIKG
CHHHHHHHHHHHHHC
36.4224719451
31UbiquitinationSSLLRRIKGKLFTWN
HHHHHHHHCCHHHHH
48.4523000965
33UbiquitinationLLRRIKGKLFTWNIL
HHHHHHCCHHHHHHH
35.1123000965
33 (in isoform 2)Ubiquitination-35.1121890473
33 (in isoform 1)Ubiquitination-35.1121890473
58 (in isoform 3)Ubiquitination-3.7021906983
105UbiquitinationDNLLVILKRKWWKYI
CCEEEEECHHHHHHH
40.592190698
105 (in isoform 2)Ubiquitination-40.5921890473
105 (in isoform 1)Ubiquitination-40.5921890473
129PhosphorylationNYVIVRAYQYTTLTS
CEEEEEEEEECCCCC
7.4721406692
131PhosphorylationVIVRAYQYTTLTSVQ
EEEEEEEECCCCCHH
6.7621406692
132PhosphorylationIVRAYQYTTLTSVQL
EEEEEEECCCCCHHH
10.3721406692
133PhosphorylationVRAYQYTTLTSVQLL
EEEEEECCCCCHHHH
24.0921406692
135PhosphorylationAYQYTTLTSVQLLDC
EEEECCCCCHHHHHH
25.4321406692
136PhosphorylationYQYTTLTSVQLLDCF
EEECCCCCHHHHHHH
15.8121406692
152PhosphorylationIPVLMALSWFILHAR
HHHHHHHHHHHHHHH
15.4821406692
339PhosphorylationYCSTPTRTAEPAESS
HCCCCCCCCCCCCCC
37.5425850435
345PhosphorylationRTAEPAESSVPPVTS
CCCCCCCCCCCCCCE
38.4528122231
346PhosphorylationTAEPAESSVPPVTSI
CCCCCCCCCCCCCEE
30.1025850435
351PhosphorylationESSVPPVTSIGIDNL
CCCCCCCCEEEECCC
22.0228122231
352PhosphorylationSSVPPVTSIGIDNLG
CCCCCCCEEEECCCC
21.0325850435
361UbiquitinationGIDNLGLKLEENLQE
EECCCCCCHHHHHHH
52.6433845483
369PhosphorylationLEENLQETHSAVL--
HHHHHHHHHHHCC--
14.2630266825
371PhosphorylationENLQETHSAVL----
HHHHHHHHHCC----
27.7430266825

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of S35F2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of S35F2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of S35F2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of S35F2_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of S35F2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5, AND MASSSPECTROMETRY.

TOP